AB0458 B Cells Depletion for the Treatment of Systemic Autoimmune Diseases

doi 10.1136/annrheumdis-2017-eular.6402

Full Text

Abstract

Available in

Date

June 1, 2017

Authors

ML Velloso Feijoo

S Rodriguez Montero

N Plaza Aulestia

JL Marenco de la Fuente

Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Regulatory B Cells in Autoimmune Diseases

Cellular and Molecular Immunology

Infectious Diseases

English

The Use of Stem Cells for the Treatment of Autoimmune Diseases

Brazilian Journal of Medical and Biological Research

English

Audiovestibular Symptoms in Systemic Autoimmune Diseases

Journal of Immunology Research

English

Targeting Treg Signaling for the Treatment of Autoimmune Diseases

Current Opinion in Immunology

English

Inflammation and Dysmetabolism in Systemic Autoimmune Diseases

Journal of Immunology Research

English

Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as a Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases

Recent Patents on Inflammation and Allergy Drug Discovery

English

Autoantibodies in Systemic Autoimmune Diseases: Specificity and Pathogenicity

Journal of Clinical Investigation

English

The Clinical Significance of the Dense Fine Speckled Immunofluorescence Pattern on HEp-2 Cells for the Diagnosis of Systemic Autoimmune Diseases

Clinical and Developmental Immunology

English

Parasite-Derived Proteins for the Treatment of Allergies and Autoimmune Diseases

Frontiers in Microbiology

English